Saranac Partners’s Cardinal Health CAH Stock Holding History

Saranac Partners’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-600	Closed	-$94.2K	–	92
2025 Q3	$94.2K	Buy	+600	New	+$92.7K	0.02%	265

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Saranac Partners's CAH Position: Q4 2025 in Review

Saranac Partners sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 600 shares — an estimated $94.2K sold.

Saranac Partners first reported a position in CAH in Q3 2025 and held it in 1 quarter. The position peaked at $94.2K in Q3 2025. 1,408 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

Saranac Partners reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
Saranac Partners sold 600 Cardinal Health shares in Q4 2025, an estimated $94.2K.
Saranac Partners first reported a position in Cardinal Health in Q3 2025 and held it in 1 quarter.
Saranac Partners's Cardinal Health position peaked at $94.2K in Q3 2025.
1,408 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Saranac Partners's 13F filing for Q4 2025, filed 6 Feb 2026.